Study design of the Akershus Cardiac Examination (ACE) 4 Study: Pragmatic randomized-controlled trial assessing the effect of early biomarker measurements and structured feedback in unselected patients hospitalized with tachypnea [0.03%]
阿克谢斯心脏检查（ACE）4研究设计：一项实用随机对照试验，评估早期生物标志物测量和结构化反馈对以呼吸急促为住院指征的未经挑选患者的影响
Rahul Bhatnagar,Kristine Lippestad,Torbjørn Wisløff et al.
Rahul Bhatnagar et al.
Background: Patients with acute tachypnea pose diagnostic challenges in the Emergency Department (ED). Biomarkers such as N-terminal pro-B-type natriuretic peptide (NT-proBNP) and cardiac troponin T (cTnT) improve diagnos...
Inflammatory Bowel Disease is Associated with Pericarditis: A Cross-Sectional Study in an NIH-Sponsored, Nationwide Database [0.03%]
基于国立卫生研究院赞助的全国数据库的一项横断面研究：炎症性肠病与心包炎相关
Dane Rucker,Tanay Shah,Jill T Shah et al.
Dane Rucker et al.
Introduction Inflammatory bowel disease (IBD) is a chronic inflammatory condition affecting approximately 2.39 million individuals in the United States. IBD is associated with extraintestinal manifestations (EIMs), among which pericarditis ...
The influence of left ventricular ejection fraction on long-term survival of patients after transcatheter edge-to-edge mitral valve repair [0.03%]
左心室射血分数对经导管缘对缘二尖瓣修复术后长期生存率的影响分析
Felix Ausbuettel,Sebastian Barth,Georgios Chatzis et al.
Felix Ausbuettel et al.
Background: Transcatheter edge-to-edge repair (M-TEER) has emerged as an effective treatment for high-risk patients suffering from mitral regurgitation (MR), alleviating symptoms and improving outcomes. However, the progn...
Update on chronic total occlusion percutaneous coronary intervention indications and evidence [0.03%]
慢性完全闭塞冠脉介入治疗的指征及证据更新
QiHeng Wan,Song Wen,Zehan Huang et al.
QiHeng Wan et al.
Background: With more specific indications and improved technical support, chronic total occlusion (CTO) percutaneous coronary intervention (PCI) has achieved substantial breakthroughs in recent years. Procedural success ...
SUBCLINICAL ATHEROSCLEROTIC CORONARY ARTERY DISEASE: CONSIDERATIONS ON A NEW MODIFIER OF CARDIOVASCULAR RISK [0.03%]
冠状动脉非梗阻性亚临床动脉粥样硬化疾病对心血管风险评估的影响
Andrea Rubboli,Dan Atar
Andrea Rubboli
Prognostic Value of Time in Serum potassium Target Range Among Patients With Heart Failure and preserved ejection fraction [0.03%]
射血分数保留的心力衰竭患者血钾水平在目标范围内时间的比例与其预后的关联研究
Mengmeng Wang,Wenming Bian,Kangyu Chen et al.
Mengmeng Wang et al.
Introduction: Heart failure (HF) imposes a substantial disease burden, where dyskalemia is an established prognostic factor. Although time in therapeutic range (TTR) demonstrates clinical utility across cardiovascular con...
Diagnosis and treatment of right-sided valve disease in cardiac carcinoid syndrome: a systematic review [0.03%]
心脏类癌综合征右心瓣膜病变的诊断和治疗：系统性综述
Bernardo Nascimento Lourenço,Bruno Dos Santos Vilhena Pereira,Gelcio Luiz Quintella Mendes et al.
Bernardo Nascimento Lourenço et al.
Background: Carcinoid heart disease (CaHD) is a severe complication of neuroendocrine tumors, characterized by progressive fibrotic involvement of right-sided heart valves due to serotonin and other vasoactive substances....
Prevalence and predictors of obstructive sleep apnea in men and women from an outpatient clinic cohort: Focus on clinical characteristics, cardiovascular disease and serum biomarkers [0.03%]
来自门诊队列的男性和女性阻塞性睡眠呼吸暂停的患病率及预测因素：重点关注临床特征，心血管疾病和血清生物标志物
Andrea Romarheim,Ragnhild Stokke Lundetræ,Ingvild West Saxvig et al.
Andrea Romarheim et al.
Background: Obstructive sleep apnea (OSA) is more prevalent in men than women, and the exact explanation for this is unknown. The aims of the present study were to explore the prevalence and predictors of OSA in men and w...
From Provocation to Precision: The Evolution of Flow-Based Thrombosis Models [0.03%]
从挑衅到精确：血栓流体动力学模型的发展演变规律
Torben Bjerregaard Larsen
Torben Bjerregaard Larsen
Comment
Cardiology. 2025 Dec 10:1-2. DOI:10.1159/000549613 2025
Long-term administration of multikinase inhibitors is a potential risk factor for atherosclerosis in patients with thyroid cancer [0.03%]
甲状腺癌患者长期服用多激酶抑制剂可能是动脉粥样硬化的一种潜在风险因素
Nao Muraoka,Takuya Oyakawa,Ayano Fujita et al.
Nao Muraoka et al.
Introduction: Vascular endothelial growth factor inhibitors are key drugs for cancer treatment as they inhibit angiogenesis. However, they also promote atherosclerosis in normal vessels, though the clinical significance o...